(ENSG) The Ensign - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012
ENSG: Skilled Nursing, Senior Living, Rehabilitative Services
The Ensign Group, Inc. (NASDAQ:ENSG) operates as a prominent healthcare provider specializing in skilled nursing, senior living, and rehabilitative services. The company is structured into two primary segments: Skilled Services and Standard Bearer. The Skilled Services segment offers comprehensive care, including short-term and long-term nursing for patients with chronic conditions and the elderly, along with specialized services such as on-site dialysis, ventilator care, and cardiac management. Additionally, this segment provides essential services including accommodations, nutritional programs, social activities, and recreational entertainment. The Standard Bearer segment focuses on leasing post-acute care facilities to healthcare operators, diversifying the companys revenue streams. Ensign also provides ancillary services like digital x-rays, ultrasounds, and pharmacy services, enhancing their holistic care approach. With operations across multiple U.S. states, the company has established a strong presence in the post-acute care sector, likely through strategic expansions and acquisitions. Headquartered in San Juan Capistrano, California, Ensign was incorporated in 1999 and has grown to become a key player in the healthcare industry.
Based on technical and fundamental analysis, the three-month forecast for ENSG indicates a potential rebound despite current bearish trends. Technically, the stocks price is below its 20, 50, and 200-day SMAs, suggesting short-term weakness. The Average True Range (ATR) of 3.88 indicates moderate volatility, signaling possible price fluctuations. However, fundamentally, the companys healthy return on equity (RoE) of 16.19% and a forward P/E of 20.49 suggest expected earnings growth, which may offset the current downturn. The price-to-book (P/B) ratio of 4.01 reflects market confidence in growth prospects. Considering these factors, ENSG is expected to trade within a range of $120 to $130 over the next quarter, balancing near-term challenges with longer-term growth potential.
Additional Sources for ENSG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ENSG Stock Overview
Market Cap in USD | 7,323m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2007-11-09 |
ENSG Stock Ratings
Growth Rating | 78.2 |
Fundamental | 74.4 |
Dividend Rating | 50.1 |
Rel. Strength | 7.31 |
Analysts | 4.4/5 |
Fair Price Momentum | 136.76 USD |
Fair Price DCF | 72.06 USD |
ENSG Dividends
Dividend Yield 12m | 0.19% |
Yield on Cost 5y | 0.68% |
Annual Growth 5y | 3.68% |
Payout Consistency | 98.6% |
ENSG Growth Ratios
Growth Correlation 3m | -47.7% |
Growth Correlation 12m | 10.4% |
Growth Correlation 5y | 91.9% |
CAGR 5y | 30.78% |
CAGR/Max DD 5y | 1.11 |
Sharpe Ratio 12m | 0.70 |
Alpha | 3.98 |
Beta | 0.131 |
Volatility | 31.84% |
Current Volume | 482.4k |
Average Volume 20d | 396.9k |
As of May 01, 2025, the stock is trading at USD 128.99 with a total of 482,360 shares traded.
Over the past week, the price has changed by +4.96%, over one month by -0.99%, over three months by -8.82% and over the past year by +8.15%.
Yes, based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 74.38 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of May 2025 is 136.76. This means that ENSG is currently overvalued and has a potential downside of 6.02%.
The Ensign has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ENSG.
- Strong Buy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 147.7 in May 2026. The stock is currently trading at 128.99. This means that the stock has a potential upside of +14.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 165.8 | 28.5% |
Analysts Target Price | 165.8 | 28.5% |
ValueRay Target Price | 147.7 | 14.5% |